MECHELEN, BELGIUM--(Marketwire - December 19, 2011) -
Mechelen, Belgium; 19 December 2011 - Galapagos NV (BRUX: GLPG)
announced today a capital increase arising from employee warrant exercises.
Since its inception in 1999, Galapagos has used warrant plans to
incentivize personnel and management and have them share in the success
of the company. Following warrant exercises during the exercise period
from 28 November through 12 December 2011, Galapagos issued 1,575 new
ordinary shares on 19 December 2011 for a total capital increase
(including issuance premium) of EUR11,214.00. No member of the Board or
Executive Committee exercised warrants.
To date, Galapagos' total share capital amounts to EUR142,928,662.81; the
total number of securities conferring voting rights is 26,421,441, which
is also the total number of voting rights (the "denominator"), and all
securities conferring voting rights and all voting rights are of the same
category. The total number of rights (warrants) to subscribe to not
yet issued securities which confer voting rights is 3,342,602, which is
also the total number of voting rights that may result from the exercise
of these warrants. Galapagos does not have any convertible bonds or
shares without voting rights outstanding.
Galapagos (BRUX: GLPG) (PINKSHEETS: GLPYY) is a mid-size biotechnology
company specialized in the discovery and development of small molecule
and antibody therapies with novel modes-of-action. The Company is
progressing GLPG0634, as well as one of the largest pipelines in
biotech, with seven programs in development and over 50 discovery
programs. The Galapagos Group has about 800 employees and operates
facilities in six countries, with global headquarters in Mechelen, Belgium.
More info at: www.glpg.com
This release may contain forward-looking statements, including,
without limitation, statements containing the words "believes,"
"anticipates," "expects," "intends," "plans," "seeks," "estimates,"
"may," "will," "could," "stands to," and "continues," as well as
similar expressions. Such forward-looking statements may involve known
and unknown risks, uncertainties and other factors which might cause the
actual results, financial condition, performance or achievements of
Galapagos, or industry results, to be materially different from any
historic or future results, financial conditions, performance or
achievements expressed or implied by such forward-looking statements.
Given these uncertainties, the reader is advised not to place any undue
reliance on such forward-looking statements. These forward-looking
statements speak only as of the date of publication of this document.
Galapagos expressly disclaims any obligation to update any such forward-
looking statements in this document to reflect any change in its
expectations with regard thereto or any change in events, conditions or
circumstances on which any such statement is based, unless required by law
This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients. The owner of this announcement warrants that: (i) the
releases contained herein are protected by copyright and other applicable
laws; and (ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE